ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

Current stock price

82.42 EUR
-3.42 (-3.98%)
Last:

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • ABL had positive earnings in the past year.
  • In the past year ABL had a positive cash flow from operations.
  • In the past 5 years ABL has always been profitable.
  • Each year in the past 5 years ABL had a positive operating cash flow.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.52%, ABL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
  • The Return On Equity of ABL (12.51%) is better than 79.37% of its industry peers.
  • ABL has a better Return On Invested Capital (9.17%) than 77.78% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 10.15%.
  • The 3 year average ROIC (8.63%) for ABL is below the current ROIC(9.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABL's Profit Margin of 14.72% is amongst the best of the industry. ABL outperforms 90.48% of its industry peers.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • Looking at the Operating Margin, with a value of 18.85%, ABL is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ABL has grown nicely.
  • ABL's Gross Margin of 56.68% is in line compared to the rest of the industry. ABL outperforms 53.97% of its industry peers.
  • ABL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ABL.DE Health Analysis

2.1 Basic Checks

  • ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ABL has been increased compared to 1 year ago.
  • Compared to 5 years ago, ABL has less shares outstanding
  • Compared to 1 year ago, ABL has an improved debt to assets ratio.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 4.81 indicates that ABL is not in any danger for bankruptcy at the moment.
  • ABL has a Altman-Z score of 4.81. This is in the better half of the industry: ABL outperforms 79.37% of its industry peers.
  • ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.75, ABL belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
  • A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
  • ABL has a better Debt to Equity ratio (0.19) than 74.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.81
ROIC/WACC1.09
WACC8.42%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.58, ABL is in line with its industry, outperforming 55.56% of the companies in the same industry.
  • A Quick Ratio of 1.18 indicates that ABL should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.18, ABL perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABL.DE Growth Analysis

3.1 Past

  • ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • The Revenue has been growing slightly by 5.67% in the past year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.86, the valuation of ABL can be described as rather expensive.
  • Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
  • ABL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • ABL is valuated rather expensively with a Price/Forward Earnings ratio of 17.03.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
  • ABL is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.86
Fwd PE 17.03
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.81
EV/EBITDA 15.63
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.76
PEG (5Y)2.65
EPS Next 2Y10.46%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.45%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.23, ABL pays a bit more dividend than its industry peers.
  • ABL's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.45%

5.2 History

  • On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
  • ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (4/16/2026, 1:49:06 PM)

82.42

-3.42 (-3.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.92%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap143.22B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80.57
Price Target115.79 (40.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.45%
Yearly Dividend2.03
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)1.34%
PT rev (3m)-7.03%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 18.86
Fwd PE 17.03
P/S 3.81
P/FCF 22.81
P/OCF 17.64
P/B 3.24
P/tB 7.48
EV/EBITDA 15.63
EPS(TTM)4.37
EY5.3%
EPS(NY)4.84
Fwd EY5.87%
FCF(TTM)3.61
FCFY4.38%
OCF(TTM)4.67
OCFY5.67%
SpS21.66
BVpS25.47
TBVpS11.03
PEG (NY)1.76
PEG (5Y)2.65
Graham Number50.0403 (-39.29%)
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.81
F-Score6
WACC8.42%
ROIC/WACC1.09
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


How profitable is ABBOTT LABORATORIES (ABL.DE) stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.


What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?

The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.


Is the dividend of ABBOTT LABORATORIES sustainable?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.